<?xml version="1.0" encoding="UTF-8"?>
<ref id="cit0039">
 <label>39.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Shanmugaraj</surname>
    <given-names>B</given-names>
   </name>, 
   <name name-style="western">
    <surname>Siriwattananon</surname>
    <given-names>K</given-names>
   </name>, 
   <name name-style="western">
    <surname>Wangkanont</surname>
    <given-names>K</given-names>
   </name>, 
   <name name-style="western">
    <surname>Phoolcharoen</surname>
    <given-names>W</given-names>
   </name>
  </person-group>
  <article-title>Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)</article-title>. 
  <source>Asia Pac J Allergy Immunol</source>. 
  <year>2020</year>;
  <volume>38</volume>(
  <issue>1</issue>):
  <fpage>10</fpage>â€“
  <lpage>18</lpage>. doi:
  <pub-id pub-id-type="doi">10.12932/AP-200220-0773</pub-id>.
 </mixed-citation>
</ref>
